KELLIE NEELY: Open Payments
NPI 1437529369 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 77 payments from 17 companies in 2025. Trend: 2023 $260 · 2024 $204 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 15 | $374 |
| GlaxoSmithKline, LLC. | 13 | $258 |
| AstraZeneca Pharmaceuticals LP | 6 | $207 |
| Verona Pharma, Inc. | 12 | $203 |
| GENZYME CORPORATION | 6 | $183 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $158 |
| Lilly USA, LLC | 2 | $130 |
| Grifols USA, LLC | 4 | $91 |
| Viatris Specialty LLC | 3 | $56 |
| Becton, Dickinson and Company | 1 | $39 |
Products named: DUPIXENT, Ohtuvayre, NUCALA, ZEPBOUND, BREZTRI, TRELEGY ELLIPTA, Xembify, TEZSPIRE.
Industry payments across GA — which companies pay providers there.
